Utilising genomic data in pharmacotherapy will reduce the number of incorrect prescriptions. On the other hand, if a person knows that he/she has a digestion-related genetic trait that augments or weakens, for example, the breaking down of caffeine into energy and building materials, that knowledge may have a positive effect on his/her lifestyle. In the future, the algorithms of genetic databases linked to electronic patient record systems could automatically warn against possible adverse drug reactions and provide advice on the most effective alternative.
Read rest of the article here: https://www.elixir-finland.org/en/striving-for-a-national-service-to-utilise-genomic-data-in-health-care/
ELIXIR is partly funded by the European Commission